Exjade - deferasirox
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0469 |
| Proprietary Name: | Exjade |
| Suffix: | |
| Non-Proprietary Name: | deferasirox |
| Dosage Form: | TABLET, FOR SUSPENSION |
| Method: | ORAL |
| Original Marketing Date: | 30-11-2005 |
| Category Name: | NDA |
| Application Number: | NDA021882 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | DEFERASIROX |
| Active Numerator Strength: | 250 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA] |
| DEA Schedule: |